Abstract: Described embodiments include an apparatus, including a display and a processor. The processor is configured to navigate a catheter to a particular location within a body of a subject, using each one of a plurality of electrodes coupled to the body of the subject. The processor is further configured to identify, subsequently, from a signal that represents an impedance between a given pair of the electrodes, that a phrenic nerve of the subject was stimulated by a pacing current passed from the catheter into tissue of the subject at the particular location, and to generate an output on the display, in response to the identifying. Other embodiments are also described.
Abstract: Systems and methods are provided for a respiratory sensor for a medical monitoring system that does not require an internal power source. The systems and methods adjust an electrical characteristic of a respiratory sensor based on a property of interest of an airflow path, receiving an excitation signal, and generating a response based on the excitation signal and the electrical characteristic.
Type:
Grant
Filed:
December 20, 2016
Date of Patent:
April 27, 2021
Assignee:
General Electric Company
Inventors:
Ville Vartiovaara, Otto Valtteri Pekander
Abstract: Apparatuses and methods for displaying a blood pressure monitoring instrument reading along with inaccuracy values that vary over apparatus life and according to current operating conditions are disclosed. These inaccuracy values account for variability under different operating environments, over time and number of device measurement cycles, and across the range of possible instrument reading conditions. Determination of inaccuracy values may be based both on apparatus history and measurement under the current operating condition. Methods can further include informing a user of confidence in the instrument's current measurements based on the instrument's measurements and inaccuracy.
Abstract: A glucose meter includes a housing, and a first chamber and a second chamber defined in the housing. A first barrel is installed in the first chamber and adapted to accommodate multiple lancets therein. A second barrel is installed in the second chamber and adapted to accommodate multiple test strips therein. Additionally, each of the first and second chamber includes a hinged lid which is lifted to expose the first and second barrel from the top end of the first and second chamber. The hinged lids are actuated by buttons on the housing. The lancets are adapted to prick a user's finger in order to reveal blood. A user then positions the blood on the test strip to be absorbed and tested by the glucose meter.
Abstract: A system is disclosed including: one or more electroencephalography (EEG) sensor nodes in a fully reconfigurable sensor network configured to detect electrical signals indicating activity of a brain of a subject and to transmit signal information relating to the detected electrical signals, each EEG sensor node embodying an analog front end (AFE) circuit, and a centralized command control node (CCN) in the sensor network in communication with the one or more EEG sensor nodes and configured to receive the transmitted signal information from the one or more EEG sensor nodes and to perform a processing technique on the received information resulting in processed signal data, wherein the one or more EEG sensor nodes are configured to detect the electrical signals without a driven right leg (DRL) circuit in the sensor network.
Abstract: A breath sampling device including a housing having a fluid inlet positioned at a fluid inlet end, a fluid outlet positioned at a fluid outlet end, a fluid channel extending between the fluid inlet and the fluid outlet, and a sensor fluidly coupled to the fluid channel. The sensor is structurally configured to detect a presence of a target gas in a gas sample and a filter assembly fluidly coupled to the fluid channel and positioned between the fluid inlet and the sensor. The filter assembly is structurally configured to absorb heat, water vapor, or a combination thereof.
Type:
Grant
Filed:
September 11, 2015
Date of Patent:
April 6, 2021
Assignee:
Sensirion AG
Inventors:
Joseph R. Stetter, Vinay Patel, Melvin Findlay
Abstract: A device (10) to be inserted in a woman's vagina to aid in measuring muscles operatively associated with the woman's vagina. The device (10) includes a motion detector (24) that is a gyroscope and that detects angular movement about at least one axis, and preferably detects angular movement about three mutually perpendicular axes. Preferably the motion detector (24) is a combination of a gyroscope and accelerometer.
Abstract: A gas flow-focusing device (FFD) may include a cylindrical body that may include a funneling part to receive exhaled CO2-enriched air, and a CO2 sampling part. The CO2 sampling part and the funneling part are in fluid flow communication. The CO2 sampling part may include a CO2 sampling chamber to accept the CO2-enriched air, and a CO2 sampling tube to sample the CO2-enriched air. The funneling part and the CO2 sampling part may structurally form between them a ring-shaped gas chamber to contain a pressurized propellant gas, and a hollow channel in order to channel the pressurized propellant gas from the gas chamber to the CO2 sampling chamber. The gas chamber may include a gas intake opening through which propellant gas may fill the gas chamber. A prong-free cannula (PFC) may include two FFDs for sampling CO2, and a plurality of apertures for providing, there through, oxygen.
Abstract: A method for monitoring autoregulation includes, using a processor, receiving a blood pressure signal, a regional oxygen saturation signal, and a blood volume signal from a patient. The method also includes determining a first linear correlation between the blood pressure signal and the regional oxygen saturation signal and determining a second linear correlation between the blood pressure signal and the blood volume signal. The method also includes determining a confidence level associated with the first linear correlation based at least in part on the second linear correlation and providing a signal indicative of the patient's autoregulation status to an output device based on the linear correlation and the confidence level.
Type:
Grant
Filed:
June 16, 2016
Date of Patent:
March 2, 2021
Assignee:
Covidien LP
Inventors:
Paul S. Addison, Dean Montgomery, James N. Watson
Abstract: An apparatus for collecting volatile organic compounds from a gas sample such as alveolar breath or room air comprises an exhaust portion having at least a flow measuring device, and a discriminating device for distinguishing between alveolar and non-alveolar breath. The apparatus further comprises a collection portion distinct from and parallel with the exhaust portion having at least a collection component for receiving and concentrating gas samples within a collection chamber and a sampling component having a plurality of sampling devices for receiving the concentrated gas sample from the collection chamber and isolating VOCs contained in the gas sample. The collection chamber is compressible via a drive mechanism for precisely actuating the chamber to draw a gas sample into the collection chamber and circulating the sample to the sampling devices. Use of a drive mechanism enables the exhaust portion to be distinct from the collection portion, thereby mitigating cross-contamination therebetween.
Abstract: A method for dynamic analysis of a physiological parameter of a user includes: generating a first event label corresponding to a first measurement value of the physiological parameter measured at a first time point; generating a second event label corresponding to a second measurement value of the physiological parameter measured at a second time point; calculating a time difference between the first and second time points; calculating a measurement value difference between the first and second measurement values when a time difference between the first and second time points is smaller than a time length threshold; and providing an analysis outcome based on the first and second event labels and the measurement value difference.
Abstract: A system for monitoring a physiological condition of a user includes a first measuring apparatus for personal use, a second measuring apparatus for use by medical professionals, and a server. The first measuring apparatus measures a first physiological parameter of the user. The second measuring apparatus measures a second physiological parameter of the user. The server receives the first and second physiological parameters measured by the first and second measuring apparatuses. The measured values of the first and second physiological parameters are associated with a disease condition, a health condition, a nutrient intake condition, a fitness condition or an exercise condition of the user.
Abstract: A device adapted for determining cardiac viability, wherein said device includes: a cannula having a hollow body and at least a distal end adapted for insertion into a heart and operator end for adapted for an operator to position the catheter in the ventricular apex and adapted for connection to a plumbing system; an inflatable balloon positioned near to the distal end in fluid communication with the hollow body to allow for selected inflation of the balloon, a controller adapted to calculate the viability of the heart from pressure data detected within cannula or balloon which is inflated to various degrees with an incompressible fluid.
Type:
Grant
Filed:
May 26, 2014
Date of Patent:
February 9, 2021
Assignee:
Organ Transport PTY LTD
Inventors:
Ruchong Ou, John Woodard, Jonathan Cavendish Nevile
Abstract: A wheezing detection apparatus includes a breathing sound detection unit that detects a breathing sound of a measurement subject and acquires a breathing sound signal in a time series expressing the breathing sound. The wheezing detection apparatus includes a determination processing unit that, in each pre-determined processing unit period, converts the breathing sound signal into a frequency space to acquire a frequency spectrum of the breathing sound, and based on a height and a width of a peak in the frequency spectrum, determines whether or not the peak indicates wheezing.
Abstract: Apparatus, system, and computer readable media determine the probability of visual recognition of an image by a subject using electroencephalography (EEG) corresponding to a Visual Evoked Potential (VEP). The apparatus comprises means for presenting a series of visual stimuli corresponding to said image to evoke EEG signals. The visual stimuli of the image are presented in an orientation sequence based on a timing cycle. At least one prism is provided for placement in front of the series of visual stimuli corresponding to said image. The EEG signals evoked in response to said visual stimuli and said prism placed in front of said visual stimuli are recorded and processed by a processor. VEP is generated corresponding to the presence of a shift and thereby provides object statistic reliability of the visual recognition of the image by the subject.
Abstract: An apparatus for early detection of sepsis in a host is disclosed. The apparatus includes a first sensor to directly measure a glucose level, a second sensor to directly measure a lactate level and a third sensor to directly measure a tissue oxygen level. The first sensor, the second sensor, and the third sensor all being inserted at a single point of entry in a subcutaneous space of the host such that a predetermined correlation between the glucose level, lactate level, and tissue oxygen level signals conditions related to sepsis.
Abstract: Systems and methods are presented for the diagnosis of middle ear pathological conditions based on spectral signatures. Preferred embodiments provide for detection of one or more analytes from the tympanic membrane. Devices use spectral measurements including spectral imaging to non-invasively identify middle ear pathological conditions including cholesteatoma and acute otitis media by providing real-time information of differentially expressed molecules. Devices and methods can also be used to non-invasively detect and quantify blood analytes from the tympanic membrane.
Type:
Grant
Filed:
September 15, 2016
Date of Patent:
December 29, 2020
Assignees:
Massachusetts Institute of Technology, Connecticut Children's Medical Center
Inventors:
Rishikesh Pandey, Nicolas Spegazzini, Luis H. Galindo, Ramachandra Dasari, Tulio Alberto Valdez
Abstract: A cradle and methods of using embodiments of the cradle are described. The cradle has a proximal side and a distal side, where the proximal side has a skin attachment member for releasable attachment to a patient's skin. The distal side includes a device attachment member configured to attach an initially separate medical device. The cradle comprises an electronically controlled optical indication device, the electronically controlled optical indication device being configured to provide optical indications to the patient when the cradle is attached to the patient's skin.
Abstract: Spirometer, mouthpiece tube and inspection method thereof. The spirometer includes at least the mouthpiece tube and an ultrasound detector configured to detect the ultrasound generated by the gas flowing through the mouthpiece tube, wherein the mouthpiece tube has a shell having an opened end, a closed or opened end, and an ultrasonic generator configured to be inserted into different portions of the shell in different situations. Therefore, by inserting the ultrasonic generator into different portions of the shell during expiration and inspiration, the gas flow during expiration and inspiration may be converted into the ultrasonic signal and then maybe detected and analyzed.
Type:
Grant
Filed:
August 15, 2017
Date of Patent:
December 15, 2020
Inventors:
Chia-Hung Chen, Hsiao-Pao Yen, Chia-Chi Su, Liang-Lin Yen
Abstract: Apparatus for optical tissue detection and discrimination between a tissue of a user and non-tissue materials and method of optical tissue detection and discrimination between a tissue of a user and non-tissue materials are provided. The apparatus for optical tissue detection includes one or more of light sources. The apparatus can further include at least one photodetector. A processor can be operable to determine whether the detected light is from a tissue of a user.
Type:
Grant
Filed:
September 9, 2016
Date of Patent:
December 15, 2020
Assignee:
Happy Health, Inc.
Inventors:
Paulo E. Xavier Da Silveira, Nithin O. Rajan, Dustin M. Freckleton